Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.3389/fphar.2017.00566

Título: Verapamil blocks scopolamine enhancement effect on memory consolidation in passive avoidance task in rats
Fecha de publicación: 23-ago-2017
Editorial: Frontiers Media
Cita bibliográfica: Front Pharmacol. 2017 8:566.
ISSN: Electronic: 1663-9812
Materias relacionadas: CDU::6 - Ciencias aplicadas
Palabras clave: Memory consolidation
Passive avoidance
Verapamil
Scopolamine
Rat
Resumen: Our recent data have indicated that scopolamine, a non-selective muscarinic receptor antagonist, improves memory consolidation, in a passive avoidance task, tested in rats. It has been found that verapamil, a phenylalkylamine class of the L-type voltage-dependent calcium channel antagonist, inhibits [3H] N-methyl scopolamine binding to M1 muscarinic receptors. However, there are no data about the effect of verapamil on memory consolidation in the passive avoidance task, in rats. The purpose of the present study was to examine the effects of verapamil (0.5, 1.0, 2.5, 5.0, 10, or 20 mg/kg i.p.) as well as the interaction between scopolamine and verapamil on memory consolidation in the step-through passive avoidance task, in Wistar rats. Our results showed that verapamil (1.0 and 2.5 mg/kg) administered immediately after the acquisition task significantly increased the latency of the passive avoidance response, on the 48 h retested trial, improving memory consolidation. On the other hand, verapamil in a dose of 5 mg/kg, that per se does not affect memory consolidation, significantly reversed the memory consolidation improvement induced by scopolamine (1 mg/kg, i.p., administered immediately after verapamil treatment) but did not change the passive avoidance response in rats treated by an ineffective dose of scopolamine (30 mg/kg). In conclusion, the present data suggest that (1) the post-training administration of verapamil, dose-dependently, improves the passive avoidance response; (2) verapamil, in ineffective dose, abolished the improvement of memory consolidation effect of scopolamine; and (3) exists interaction between cholinergic muscarinic receptors and calcium homeostasis-related mechanisms in the consolidation of emotional memory.
Autor/es principal/es: Giménez de Béjar, Verónica
Caballero Bleda, María
Popovic, Natalija
Popovic, Miroljub
Facultad/Departamentos/Servicios: Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Anatomía Humana y Psicobiología
Versión del editor: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00566/full
URI: http://hdl.handle.net/10201/142386
DOI: https://doi.org/10.3389/fphar.2017.00566
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 9
Derechos: info:eu-repo/semantics/openAccess
Atribución 4.0 Internacional
Descripción: © 2017 Giménez De Béjar, Caballero Bleda, Popovic and Popovic. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0/. This document is the Published version of a Published Work that appeared in final form in Frontiers in Pharmacology. To access the final edited and published work see https://doi.org/10.3389/fphar.2017.00566
Aparece en las colecciones:Artículos: Anatomía Humana y Psicobiología

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Giménez de Béjar et al., Front. Pharmacol. 2017.pdf2,21 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons